PDB37 MEALTIME INSULIN ASPART REDUCES THE LONG-TERM COST OF COMPLICATIONS COMPARED TO HUMAN INSULIN AS PART OF BASAL-BOLUS THERAPY IN POLISH TYPE 2 DIABETES PATIENTS
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64985-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)64985-6/fulltext
Title :
PDB37 MEALTIME INSULIN ASPART REDUCES THE LONG-TERM COST OF COMPLICATIONS COMPARED TO HUMAN INSULIN AS PART OF BASAL-BOLUS THERAPY IN POLISH TYPE 2 DIABETES PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64985-6&doi=10.1016/S1098-3015(10)64985-6
First page :
Section Title :
Open access? :
No
Section Order :
144